Researchers develop smart nanoparticles to target H. pylori bacteria in stomach ulcers
Scientists at Pusan National University published a study on June 10, 2026, describing new nanoparticles that deliver antibiotics directly to Helicobacter pylori infections.
New delivery system overcomes barriers
Standard antibiotic treatments often fail because drugs cannot reach bacteria hidden beneath the stomach's protective mucus layer. The research team created polydopamine-functionalized nanoparticles loaded with clarithromycin to solve this problem. These particles are designed to execute a multistage delivery cascade that bypasses biological barriers.
Targeted therapy reduces side effects
Dr. Jin-Wook Yoo stated that the platform enables precise local therapy by targeting the infection site directly. This approach aims to overcome limitations associated with higher antibiotic doses and the risk of resistance. The study was published in the Journal of Controlled Release.
Reported by one outlet
Only one outlet has published this. Nothing here has been checked against a second report, so read it as that outlet's account and follow the link below for the original.
Reported by
1 independent outlet. Headline as published. Links open the original report.